Sign in to view content

Benefits and Value of Treatment for Diabetic Macular Edema

Paul Hahn, MD, PhD, FASRS

Video
Published 2022

Related

Cost-Effectiveness of Aflibercept Monotherapy vs Bevacizumab-First Followed by Switching to Aflibercept if Needed for Diabetic Macular Edema
Mathew W. MacCumber, MD, PhD
Annual Meeting Talks
2023
DRCR.net Anti-VEGF Comparative Effectiveness Trial for Diabetic Macular Edema
Neil M. Bressler, MD
Member Podcasts
Intravitreal Liposome-Encapsulated Bromfenac for the Treatment of Refractory Diabetic Macular Edema
Hugo Quiroz-Mercado, MD
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more